The response to second-line chemotherapy
| NSCLC | SCLC | |
| Subjects | 204 | 74 |
| Number of cycles median (range) | 3 (1–22) | 3 (1–6) |
| Response | ||
| CR | 0 | 1 |
| PR | 15 | 18 |
| SD | 68 | 17 |
| PD | 83 | 23 |
| NE | 38 | 15 |
| Overall response rate n | 15 | 19 |
| % (95% CI) | 7.4 (3.8–10.9) | 25.7 (15.7–38.8) |
| Disease control rate n | 83 | 36 |
| % (95% CI) | 40.7 (33.9–49.6) | 48.6 (34.6–60.9) |
| Introduction rate of third-line chemotherapy | 46.6% | 44.6% |
NSCLC: nonsmall cell lung cancer; SCLC: small cell lung cancer; CR: complete response; PR: partial response; SD: stable disease; PD: progressive disease; NE: not evaluated.